Although data regarding elevated YKL-40 levels in CSF from early stages of AD are contradictory [16,17,22,23,24,54], our results support the increase in YKL-40 levels in CSF from AD subjects, as well as the increased astrocytic YKL-40 levels associated with astrocytosis. This evidence concerns the gene CHI3L1 and Alzheimer disease.